Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT03831438 · COMPLETED
Trial details
- NCT number
- NCT03831438
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2020-06-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.